Cargando…

Angiogenic Endothelial Cell Signaling in Cardiac Hypertrophy and Heart Failure

Endothelial cells are, by number, one of the most abundant cell types in the heart and active players in cardiac physiology and pathology. Coronary angiogenesis plays a vital role in maintaining cardiac vascularization and perfusion during physiological and pathological hypertrophy. On the other han...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gogiraju, Rajinikanth, Bochenek, Magdalena L., Schäfer, Katrin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415587/ https://www.ncbi.nlm.nih.gov/pubmed/30895179 http://dx.doi.org/10.3389/fcvm.2019.00020

Ejemplares similares

Endothelial p53 Deletion Improves Angiogenesis and Prevents Cardiac Fibrosis and Heart Failure Induced by Pressure Overload in Mice
por: Gogiraju, Rajinikanth, et al.
Publicado: (2015)

Importance of leptin signaling and signal transducer and activator of transcription-3 activation in mediating the cardiac hypertrophy associated with obesity
por: Leifheit-Nestler, Maren, et al.
Publicado: (2013)

Roles of histone acetylation sites in cardiac hypertrophy and heart failure
por: Funamoto, Masafumi, et al.
Publicado: (2023)

Impact of polyphenols on heart failure and cardiac hypertrophy: clinical effects and molecular mechanisms
por: Hedayati, Neda, et al.
Publicado: (2023)

Protective Effects of Thyroid Hormone Deprivation on Progression of Maladaptive Cardiac Hypertrophy and Heart Failure
por: Kerp, Helena, et al.
Publicado: (2021)

Cardiac ISL1-Interacting Protein, a Cardioprotective Factor, Inhibits the Transition From Cardiac Hypertrophy to Heart Failure
por: Yan, Youchen, et al.
Publicado: (2022)

Deletion of endothelial leptin receptors in mice promotes diet-induced obesity
por: Gogiraju, Rajinikanth, et al.
Publicado: (2023)

FABP3 Deficiency Exacerbates Metabolic Derangement in Cardiac Hypertrophy and Heart Failure via PPARα Pathway
por: Zhuang, Lingfang, et al.
Publicado: (2021)

A high-throughput drug screening identifies luteolin as a therapeutic candidate for pathological cardiac hypertrophy and heart failure
por: Wang, Zhenya, et al.
Publicado: (2023)

Endothelial cell-derived extracellular vesicles impair the angiogenic response of coronary artery endothelial cells
por: Carter, Nigeste, et al.
Publicado: (2022)

Extracellular Endothelial Cell-Derived Vesicles: Emerging Role in Cardiac and Vascular Remodeling in Heart Failure
por: Berezin, Alexander E., et al.
Publicado: (2020)

Circulating Soluble EPCR Levels Are Reduced in Patients with Ischemic Peripheral Artery Disease and Associated with Markers of Endothelial and Vascular Function
por: Krug, Janina, et al.
Publicado: (2023)

Correlation Between Liver Stiffness and Diastolic Function, Left Ventricular Hypertrophy, and Right Cardiac Function in Patients With Ejection Fraction Preserved Heart Failure
por: Zhang, Junyi, et al.
Publicado: (2021)

Toll-like receptors in cardiac hypertrophy
por: Zhang, Yanan, et al.
Publicado: (2023)

Protein Tyrosine Phosphatase 1B Deficiency in Vascular Smooth Muscle Cells Promotes Perivascular Fibrosis following Arterial Injury
por: Gogiraju, Rajinikanth, et al.
Publicado: (2022)

Mitochondria in Pathological Cardiac Hypertrophy Research and Therapy
por: Yang, Dan, et al.
Publicado: (2022)

TANK Promotes Pressure Overload Induced Cardiac Hypertrophy via Activating AKT Signaling Pathway
por: Pang, Yanan, et al.
Publicado: (2021)

Hispidulin Attenuates Cardiac Hypertrophy by Improving Mitochondrial Dysfunction
por: Wang, Yan, et al.
Publicado: (2020)

miR-208a in Cardiac Hypertrophy and Remodeling
por: Huang, Xing-Huai, et al.
Publicado: (2021)

Editorial: Advances in cardiac imaging and heart failure management
por: Mandoli, Giulia Elena, et al.
Publicado: (2023)

Alterations of Cardiac Protein Kinases in Cyclic Nucleotide-Dependent Signaling Pathways in Human Ischemic Heart Failure
por: Wang, Chunguang, et al.
Publicado: (2022)

Association of ACE gene D polymorphism with left ventricular hypertrophy in patients with diastolic heart failure: a case–control study
por: Bahramali, Ehsan, et al.
Publicado: (2016)

Deciphering Pro-angiogenic Transcription Factor Profiles in Hypoxic Human Endothelial Cells by Combined Bioinformatics and in vitro Modeling
por: Schmidt, Arne, et al.
Publicado: (2022)

Synergistic prognostic values of cardiac sympathetic innervation with left ventricular hypertrophy and left atrial size in heart failure patients without reduced left ventricular ejection fraction: a cohort study
por: Doi, Takahiro, et al.
Publicado: (2012)

Mechanism of histone deacetylases in cardiac hypertrophy and its therapeutic inhibitors
por: Han, Yu, et al.
Publicado: (2022)

The Future of Exercise-Based Cardiac Rehabilitation for Patients With Heart Failure
por: Passantino, Andrea, et al.
Publicado: (2021)

Cardiac Remodeling in Heart Failure: Role of Pyroptosis and Its Therapeutic Implications
por: Chai, Ruoning, et al.
Publicado: (2022)

MicroRNA-Related Strategies to Improve Cardiac Function in Heart Failure
por: Zhou, Huatao, et al.
Publicado: (2021)

Corin deficiency impairs cardiac function in mouse models of heart failure
por: Niu, Yayan, et al.
Publicado: (2023)

Falling corin and ANP activity levels accelerate development of heart failure and cardiac fibrosis
por: Gladysheva, Inna P., et al.
Publicado: (2023)

Key Player in Cardiac Hypertrophy, Emphasizing the Role of Toll-Like Receptor 4
por: Xiao, Zheng, et al.
Publicado: (2020)

Spermidine Affects Cardiac Function in Heart Failure Mice by Influencing the Gut Microbiota and Cardiac Galectin-3
por: Chen, Yufeng, et al.
Publicado: (2021)

Regulation of Endothelial Progenitor Cell Functions in Ischemic Heart Disease: New Therapeutic Targets for Cardiac Remodeling and Repair
por: Huang, Huai, et al.
Publicado: (2022)

The Roles of Cardiac Fibroblasts and Endothelial Cells in Myocarditis
por: Xuan, Yunling, et al.
Publicado: (2022)

Cardiac Imaging for the Assessment of Left Atrial Mechanics Across Heart Failure Stages
por: Bandera, Francesco, et al.
Publicado: (2022)

Editorial: Electrical management of heart failure: shaping the future of cardiac pacing and electrophysiology
por: Bressi, Edoardo, et al.
Publicado: (2023)

Effects of early phase 1 cardiac rehabilitation on cardiac function evaluated by impedance cardiography in patients with coronary heart disease and acute heart failure
por: Wang, Yishu, et al.
Publicado: (2022)

Mitochondria-associated endoplasmic reticulum membranes and cardiac hypertrophy: Molecular mechanisms and therapeutic targets
por: Luan, Yi, et al.
Publicado: (2022)

Cardiac “hypertrophy” phenotyping: differentiating aetiologies with increased left ventricular wall thickness on echocardiography
por: Ferkh, Aaisha, et al.
Publicado: (2023)

Soluble tumor endothelial marker 1 in heart failure with reduced ejection fraction: A pilot study
por: Feng, Wen-Han, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e3p6q1ic83q07dj53fkqr3k50f